The Patent Finder

Cellphire, Inc.

16 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

2
Ending by 2030
Apr 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 18, 2027
    The maintenance fee for Thrombosomes as an Antiplatelet Agent Reversal Agent (US 11,701,388) comes due Jan 18, 2027. Unpaid by Jul 19, 2027, it lapses early.
  • 2 fees due Mar 12 to 26, 2027 · next Mar 12
  • 1 fee due May 14, 2027
    The maintenance fee for Materials and Methods for Producing Blood Products (US 11,813,572) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Aug 20, 2027
    The maintenance fee for Treatment of von Willebrand disease (US 11,903,971) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
  • 1 fee due Oct 23, 2027
    The maintenance fee for Platelets loaded with anti-cancer agents (US 11,965,178) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,486,617Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use
In force
 · USPTO record
In forceUSPTO record
US 8,097,403Freeze-dried platelets, method of making and method of use as a diagnostic agent
In force
 · USPTO record
In forceUSPTO record
US 12,378,523Platelets as delivery agents
In force
 · USPTO record
In forceUSPTO record
US 11,752,468Materials and Methods for Producing Blood Products
In force
 · High confidence
In forceHigh confidence
US 11,813,572Materials and Methods for Producing Blood Products
In force
 · High confidence
In forceHigh confidence
US 12,208,122Methods of treating bleeding in a subject treated with an antiplatelet agent
In force
 · USPTO record
In forceUSPTO record
US 11,701,388Thrombosomes as an Antiplatelet Agent Reversal Agent
In force
 · Medium confidence
In forceMedium confidence
US 11,903,971Treatment of von Willebrand disease
In force
 · USPTO record
In forceUSPTO record
US 12,290,532Treatment of von Willebrand disease
In force
 · USPTO record
In forceUSPTO record
US 11,529,587Materials and Methods for Producing Blood Products
In force
 · High confidence
In forceHigh confidence
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
Also on record, not counted in the 16: 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 2 abandoned · 31 no status recorded

Showing 1 to 10 of 40, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/234,179Jun 10, 2025No status recorded
19/053,371Methods for Administering Freeze-Dried Platelet Derivative Compositions to Subjects Treated with a Factor XI InhibitorFeb 13, 2025Pending
18/949,648Methods of Administering Platelet Derivative Compositions to Reduce Bleeding in Subjects Refractory to Platelet TransfusionNov 15, 2024Pending
18/943,861Mri-Agent Loaded Platelet Compositions and Methods of Preparing and Using the SameNov 11, 2024Pending
18/943,815Methods for Administering Platelet Derivative Compositions to Subjects Afflicted with Hermansky Pudlak Syndrome or Bernard Soulier SyndromeNov 11, 2024Pending
18/737,851Methods for Preparing and Administering Cryopreserved Platelets and Platelet Derivatives Loaded with Anti-Cancer DrugsJun 7, 2024Pending
18/653,905Methods for Controlling Bleeding in a Subject Afflicted with Hermansky Pudlak Syndrome Using Platelet Derivative CompositionsMay 2, 2024Pending
18/629,638Apr 8, 2024No status recorded
18/504,080Platelet Derivatives for Treating CoagulopathyNov 7, 2023Abandoned
18/347,535Jul 5, 2023No status recorded
10 of 40 applications shown.
Pro members see all 40 published applications.
Pro members: see all 40 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited